ADEF
KYNB

Adams Diversified Equity Fund’s Kyntra Bio KYNB Stock Holding History

Adams Diversified Equity Fund’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-72
Closed -$81K – 134
2019
Q2 		$81K Sell
72
-84
-54% -$91.9K ﹤0.01% 215
2019
Q1 		$212K Buy
+156
New +$212K 0.01% 198

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Adams Diversified Equity Fund's KYNB Position: Q3 2019 in Review

Adams Diversified Equity Fund sold out of Kyntra Bio (KYNB) in Q3 2019, closing a stake of 72 shares — an estimated $81K sold.

Adams Diversified Equity Fund first reported a position in KYNB in Q1 2019 and held it in 2 quarters. The position peaked at $212K in Q1 2019. 210 funds tracked by Wall St. Rank hold KYNB as of Q3 2019.

  • Adams Diversified Equity Fund reported no remaining Kyntra Bio position as of Q3 2019 after selling out during the quarter.
  • Adams Diversified Equity Fund sold 72 Kyntra Bio shares in Q3 2019, an estimated $81K.
  • Adams Diversified Equity Fund first reported a position in Kyntra Bio in Q1 2019 and held it in 2 quarters.
  • Adams Diversified Equity Fund's Kyntra Bio position peaked at $212K in Q1 2019.
  • 210 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2019, filed 28 Oct 2019.